{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:16:54Z","timestamp":1780615014006,"version":"3.54.1"},"reference-count":38,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MSc Program in Genetic Counselling"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.2217\/pgs-2018-0179","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T11:15:56Z","timestamp":1555326956000},"page":"319-329","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Perplexed by PGX? Exploring the Impact of Pharmacogenomic Results on Medical Management, Disclosures and Patient Behavior"],"prefix":"10.1080","volume":"20","author":[{"given":"Larissa","family":"Waldman","sequence":"first","affiliation":[{"name":"Department of Genetic Counselling,\u00a0The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Shuman","sequence":"additional","affiliation":[{"name":"Department of Genetic Counselling,\u00a0The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Cohn","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chitayat","sequence":"additional","affiliation":[{"name":"Department of Genetic Counselling,\u00a0The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"},{"name":"Prenatal Diagnosis\u00a0&\u00a0Medical Genetics Program, Department of Obstetrics\u00a0&\u00a0Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Wasim","sequence":"additional","affiliation":[{"name":"Fred A Litwin Family Centre in Genetic Medicine, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hazell","sequence":"additional","affiliation":[{"name":"Medcan Health Management, Inc., Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Adverse Drug Reaction-Related Hospitalizations Among Seniors 2006 to 2011 . Ottawa: Canadian Institute for Health Information ( 2013 ). http:\/\/publications.gc.ca\/collections\/collection_2013\/icis-cihi\/H117-5-25-2013-eng.pdf ."},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-7-9"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071594"},{"key":"e_1_3_2_6_1","unstructured":"Wu C . Adverse drug reactions in the emergency department population in Ontario: analysis of national ambulatory care reporting system and discharge abstract database 2003\u20132007 [Masters Degree Thesis] . University of TorontoToronto ON Canada ( 2009 )."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.11.002"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120957"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004439"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2009.08.002"},{"key":"e_1_3_2_11_1","article-title":"Examining the coverage of pharmacogenetics tests and use of pharmacogenetics information at the population level","author":"Gauvin F-P","year":"2017","unstructured":"Gauvin F-P , WaddellK , WilsonM . Examining the coverage of pharmacogenetics tests and use of pharmacogenetics information at the population level . McMaster Health Forum ( 2017 ). www.mcmasterforum.org\/docs\/default-source\/product-documents\/rapid-responses\/examining-the-coverage-of-pharmacogenetic-tests-and-use-of-pharmacogenetic-information-at-the-population-level.pdf?sfvrsn=2 .","journal-title":"McMaster Health Forum"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304767"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-011-9476-4"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31815f524f"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-017-0297-5"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31815a9dcc"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-013-0160-2"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.012809.103532"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2013.33"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12820"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2012.01908.x"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.10.122"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2292-5"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2012.01848.x"},{"key":"e_1_3_2_25_1","article-title":"Les enjeux de la translation des technologies: Le cas des tests de pharmacog\u00e9n\u00e9tique au Qu\u00e9bec [PhD Thesis]","author":"Dubois A","year":"2009","unstructured":"Dubois A . Les enjeux de la translation des technologies: Le cas des tests de pharmacog\u00e9n\u00e9tique au Qu\u00e9bec [PhD Thesis] . ProQuest Dissertations Publishing ( 2009 ).","journal-title":"ProQuest Dissertations Publishing"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1416"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0191"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-013-9641-z"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-012-9489-7"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010814-124835"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.76"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1980"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.137"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31385"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.2671"},{"issue":"7","key":"e_1_3_2_36_1","first-page":"412","article-title":"Pharmacogenetics for the prescriber","volume":"44","author":"Pirmohamed M","year":"2016","unstructured":"Pirmohamed M . Pharmacogenetics for the prescriber . Clin. Pharmacol.44 ( 7 ), 412 \u2013 415 ( 2016 ).","journal-title":"Clin. Pharmacol."},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X08327068"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040209"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-018-0494-z"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2018-0179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:44:50Z","timestamp":1715964290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2018-0179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.2217\/pgs-2018-0179"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2018-0179","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}